Efficacy and safety of eculizumab in Guillain-Barré syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial.

Satoshi KuwabaraSusumu KusunokiMotoi KuwaharaYoshihisa YamanoYoichiro NishidaHirokazu IshidaTomoyuki KasuyaErik KuppermanQun LinGlen FrickSonoko Misawa

Published in: Journal of the peripheral nervous system : JPNS (2024)

Although well tolerated, eculizumab treatment did not show significant effects on motor function recovery compared to placebo in patients with GBS.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
phase ii
study protocol
phase ii study
open label
case report
squamous cell carcinoma
randomized controlled trial
cross sectional
locally advanced